Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

The burgeoning epidemic of morbid obesity in patients undergoing percutaneous coronary intervention: insight from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.

Buschur ME, Smith D, Share D, Campbell W, Mattichak S, Sharma M, Gurm HS.

J Am Coll Cardiol. 2013 Aug 20;62(8):685-91. doi: 10.1016/j.jacc.2013.06.004.

2.

In-hospital outcomes of percutaneous coronary interventions in extremely obese and normal-weight patients: findings from the NCDR (National Cardiovascular Data Registry).

Payvar S, Kim S, Rao SV, Krone R, Neely M, Paladugu N, Daggubati R.

J Am Coll Cardiol. 2013 Aug 20;62(8):692-6. doi: 10.1016/j.jacc.2013.05.058.

3.

The association between patient race, treatment, and outcomes of patients undergoing contemporary percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).

Khambatta S, Seth M, Rosman HS, Share D, Aronow HD, Moscucci M, Lalonde T, Dixon SR, Gurm HS.

Am Heart J. 2013 Jun;165(6):893-901.e2. doi: 10.1016/j.ahj.2013.02.030. Epub 2013 Apr 9.

PMID:
23708159
4.

A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011.

Dehmer GJ, Weaver D, Roe MT, Milford-Beland S, Fitzgerald S, Hermann A, Messenger J, Moussa I, Garratt K, Rumsfeld J, Brindis RG.

J Am Coll Cardiol. 2012 Nov 13;60(20):2017-31. doi: 10.1016/j.jacc.2012.08.966. Epub 2012 Oct 17.

5.

The clinical outcomes of percutaneous coronary intervention performed without pre-procedural aspirin.

Kenaan M, Seth M, Aronow HD, Wohns D, Share D, Gurm HS; Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).

J Am Coll Cardiol. 2013 Dec 3;62(22):2083-9. doi: 10.1016/j.jacc.2013.08.1625. Epub 2013 Sep 19.

6.
7.

Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions.

Gurm HS, Dixon SR, Smith DE, Share D, Lalonde T, Greenbaum A, Moscucci M; BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) Registry.

J Am Coll Cardiol. 2011 Aug 23;58(9):907-14. doi: 10.1016/j.jacc.2011.05.023.

8.

Preprocedural statin use in patients undergoing percutaneous coronary intervention.

Kenaan M, Seth M, Aronow HD, Naoum J, Wunderly D, Mitchiner J, Moscucci M, Gurm HS; Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).

Am Heart J. 2014 Jul;168(1):110-6.e3. doi: 10.1016/j.ahj.2014.03.016. Epub 2014 Apr 5.

PMID:
24952867
9.

Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: an analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) percutaneous coronary intervention registry.

Duvernoy CS, Smith DE, Manohar P, Schaefer A, Kline-Rogers E, Share D, McNamara R, Gurm HS, Moscucci M.

Am Heart J. 2010 Apr;159(4):677-683.e1. doi: 10.1016/j.ahj.2009.12.040.

PMID:
20362729
10.

Outcome of contemporary percutaneous coronary intervention in the elderly and the very elderly: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.

Thomas MP, Moscucci M, Smith DE, Aronow H, Share D, Kraft P, Gurm HS; Blue Cross Blue Shield of Michigan Cardiovascular Consortium.

Clin Cardiol. 2011 Sep;34(9):549-54. doi: 10.1002/clc.20926. Epub 2011 Jun 29.

11.

Retroperitoneal hematoma after percutaneous coronary intervention: prevalence, risk factors, management, outcomes, and predictors of mortality: a report from the BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) registry.

Trimarchi S, Smith DE, Share D, Jani SM, O'Donnell M, McNamara R, Riba A, Kline-Rogers E, Gurm HS, Moscucci M; BMC2 Registry.

JACC Cardiovasc Interv. 2010 Aug;3(8):845-50. doi: 10.1016/j.jcin.2010.05.013.

12.

Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries.

Yan BP, Clark DJ, Buxton B, Ajani AE, Smith JA, Duffy SJ, Shardey GC, Skillington PD, Farouque O, Yii M, Yap CH, Andrianopoulos N, Brennan A, Dinh D, Reid CM; Australasian Society of Cardiac and Thoracic Surgeons (ASCTS); Melbourne Interventional Group (MIG).

Heart Lung Circ. 2009 Jun;18(3):184-90. doi: 10.1016/j.hlc.2008.10.005. Epub 2009 Mar 5.

PMID:
19268632
14.

Temporal trends, safety, and efficacy of bivalirudin in elective percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.

Gurm HS, Smith DE, Chetcuti SJ, Share D, Khanal S, Riba A, Carter AJ, Lalonde T, Kline-Rogers E, O'Donnell M, O'Neill W, Safian R, Moscucci M; Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).

J Interv Cardiol. 2007 Jun;20(3):197-203.

PMID:
17524111
15.

The relationship of body mass index to outcomes after percutaneous coronary intervention.

Shubair MM, Prabhakaran P, Pavlova V, Velianou JL, Sharma AM, Natarajan MK.

J Interv Cardiol. 2006 Oct;19(5):388-95.

PMID:
17020562
16.

Obesity and early complications after cardiac surgery.

Yap CH, Mohajeri M, Yii M.

Med J Aust. 2007 Apr 2;186(7):350-4.

PMID:
17407431
17.

Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry.

Lancefield T, Clark DJ, Andrianopoulos N, Brennan AL, Reid CM, Johns J, Freeman M, Charter K, Duffy SJ, Ajani AE, Proietto J, Farouque O; MIG (Melbourne Interventional Group) Registry.

JACC Cardiovasc Interv. 2010 Jun;3(6):660-8. doi: 10.1016/j.jcin.2010.03.018.

18.

The changing definition of contrast-induced nephropathy and its clinical implications: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).

Slocum NK, Grossman PM, Moscucci M, Smith DE, Aronow HD, Dixon SR, Share D, Gurm HS.

Am Heart J. 2012 May;163(5):829-34. doi: 10.1016/j.ahj.2012.02.011.

PMID:
22607861
19.

Radial PCI and the obesity paradox: Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).

McDonagh JR, Seth M, LaLonde TA, Khandewal AK, Wohns DH, Dixon SR, Gurm HS.

Catheter Cardiovasc Interv. 2016 Feb 1;87(2):211-9. doi: 10.1002/ccd.26015. Epub 2015 May 22.

PMID:
26010906
20.

Differences in sex-related bleeding and outcomes after percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) registry.

Othman H, Khambatta S, Seth M, Lalonde TA, Rosman HS, Gurm HS, Mehta RH.

Am Heart J. 2014 Oct;168(4):552-9. doi: 10.1016/j.ahj.2014.07.012. Epub 2014 Jul 25.

PMID:
25262266
Items per page

Supplemental Content

Write to the Help Desk